Impact of abciximab versus tirofiban on hospital length of stay for PCI patients.

about

Outcomes with changes in prescribing of glycoprotein IIb/IIIa inhibitors in PCI.Tirofiban for the treatment of ischaemic stroke.A comparison of total hospital costs for percutaneous coronary intervention patients receiving abciximab versus tirofiban.

P2860

Q35547240-B81AA223-26EA-4C0A-AB20-DC092D745796 Q36349613-40045CB1-95B0-4BC7-8600-3CE83A725A9D Q43759391-182ED7F6-10FB-491F-80CF-9C039E7505EB

P2860

Impact of abciximab versus tirofiban on hospital length of stay for PCI patients.

Item

http://www.wikidata.org/entity/Q43540975

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Impact of abciximab versus tirofiban on hospital length of stay for PCI patients.

@en

Impact of abciximab versus tirofiban on hospital length of stay for PCI patients.

@nl

type

Item

label

Impact of abciximab versus tirofiban on hospital length of stay for PCI patients.

@en

Impact of abciximab versus tirofiban on hospital length of stay for PCI patients.

@nl

prefLabel

Impact of abciximab versus tirofiban on hospital length of stay for PCI patients.

@en

Impact of abciximab versus tirofiban on hospital length of stay for PCI patients.

@nl

P1476

Impact of abciximab versus tirofiban on hospital length of stay for PCI patients.

@en

P2093

B L Barber

http://www.w3.org/2001/XMLSchema#string

J Scherer

http://www.w3.org/2001/XMLSchema#string

M Bala

http://www.w3.org/2001/XMLSchema#string

M J Lage

http://www.w3.org/2001/XMLSchema#string

P L McCollam

http://www.w3.org/2001/XMLSchema#string

P2860

Sample Selection Bias as a Specification Error

Estimating endogenous treatment effects in retrospective data analysis.

Economic issues in glycoprotein IIb/IIIa receptor therapy.

Analysis of number needed to treat and cost of platelet glycoprotein IIb/IIIa inhibitors in percutaneous coronary interventions and acute coronary syndromes.

Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables.

Analyzing intensive care unit length of stay data: problems and possible solutions.

Comorbidity as a correlate of length of stay for hospitalized patients with acute chest pain.

Timeliness and quality of care for elderly patients with acute myocardial infarction under health maintenance organization vs fee-for-service insurance.

Glycoprotein IIb/IIIa receptor inhibitors: putting the EPIC, IMPACT II, RESTORE, and EPILOG trials into perspective.

An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.

P304

298-305

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CCD.1069

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2001-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11246240

http://www.w3.org/2001/XMLSchema#string

Impact of abciximab versus tirofiban on hospital length of stay for PCI patients.

about

P2860

P2860

Impact of abciximab versus tirofiban on hospital length of stay for PCI patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698